Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now
New York, January 9, 2026, 13:20 (EST) — Regular session Wave Life Sciences Ltd shares fell about 5.6% on Friday, down 83 cents at $14.00, after trading between $13.99 and $15.09. The drop came even as biotech exchange-traded funds rose, with the SPDR S&P Biotech ETF up about 1% and the iShares Nasdaq Biotechnology ETF up about 0.5%. The move matters because Wave has become a high-beta obesity trade in the biotech tape, and the stock has been swinging on every new data point and funding headline. Traders have been leaning on near-term catalysts rather than fundamentals, and those catalysts